MedWellAI annual ebitda
2015
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
MedWellAI EBITDA Growth & History (MWAI)
MedWellAI's calculated EBITDA was −$2.8M for fiscal 2025.
View full MedWellAI company overviewMedWellAI annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | −$2.8M | $6.3M | — |
| 2024 | 2024-06-30 | −$9.1M | $12.5M | — |
| 2023 | 2023-06-30 | −$21.6M | −$22.5M | — |
| 2022 | 2022-06-30 | $929,029 | $22.2M | — |
| 2021 | 2021-06-30 | −$21.3M | −$20.8M | — |
| 2020 | 2020-06-30 | −$439,428 | $3.7M | — |
| 2019 | 2019-06-30 | −$4.1M | $2.0M | — |
| 2018 | 2018-06-30 | −$6.1M | −$2.6M | — |
| 2016 | 2016-06-30 | −$3.5M | −$3.2M | — |
| 2015 · Jun 30 | 2015-06-30 | −$264,746 | −$322,170 | — |
| 2015 · Dec 31 | 2014-12-31 | $57,424 | — | — |
MedWellAI quarterly ebitda
Q2.14
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | −$259,480 | $1.9M | — |
| Q1 2026 | 2025-09-30 | −$317,727 | −$1.3M | — |
| Q2 2025 | 2024-12-31 | $96,918 | −$313,123 | −76.36% |
| Q1 2025 | 2024-09-30 | −$586,192 | $7.7M | — |
| Q4 2024 | 2024-06-30 | −$2.2M | $18.8M | — |
| Q3 2024 | 2024-03-31 | $1.0M | $1.3M | — |
| Q2 2024 | 2023-12-31 | $410,041 | $630,789 | — |
| Q1 2024 | 2023-09-30 | −$8.3M | −$8.1M | — |
| Q4 2023 | 2023-06-30 | −$20.9M | −$20.3M | — |
| Q3 2023 | 2023-03-31 | −$250,139 | −$809,257 | — |
| Q2 2023 | 2022-12-31 | −$220,748 | −$312,908 | — |
| Q1 2023 | 2022-09-30 | −$174,595 | −$1.1M | — |
| Q4 2022 | 2022-06-30 | −$653,870 | $4.3M | — |
| Q3 2022 | 2022-03-31 | $559,118 | $16.7M | — |
| Q2 2022 | 2021-12-31 | $92,160 | $97,894 | — |
| Q1 2022 | 2021-09-30 | $931,621 | $1.0M | — |
| Q4 2021 | 2021-06-30 | −$5.0M | −$4.9M | — |
| Q3 2021 | 2021-03-31 | −$16.2M | −$16.0M | — |
| Q2 2021 | 2020-12-31 | −$5,734 | $61,235 | — |
| Q1 2021 | 2020-09-30 | −$95,929 | −$13,538 | — |
| Q4 2020 | 2020-06-30 | −$97,953 | $834,039 | — |
| Q3 2020 | 2020-03-31 | −$192,115 | $157,915 | — |
| Q2 2020 | 2019-12-31 | −$66,969 | $115,191 | — |
| Q1 2020 | 2019-09-30 | −$82,391 | $2.5M | — |
| Q4 2019 | 2019-06-30 | −$931,992 | $4.5M | — |
| Q3 2019 | 2019-03-31 | −$350,030 | −$299,766 | — |
| Q2 2019 | 2018-12-31 | −$182,160 | $252,534 | — |
| Q1 2019 | 2018-09-30 | −$2.6M | −$2.5M | — |
| Q4 2018 | 2018-06-30 | −$5.4M | −$5.0M | — |
| Q3 2018 | 2018-03-31 | −$50,264 | $2.4M | — |
| Q2 2018 | 2017-12-31 | −$434,694 | −$31,563 | — |
| Q1 2018 | 2017-09-30 | −$161,358 | $24,893 | — |
| Q4 2016 | 2016-06-30 | −$462,111 | −$464,155 | — |
| Q3 2016 | 2016-03-31 | −$2.4M | −$2.4M | — |
| Q2 2016 | 2015-12-31 | −$403,131 | — | — |
| Q1 2016 · Sep 30 | 2015-09-30 | −$186,251 | — | — |
| Q4 2015 | 2014-12-31 | $2,044 | — | — |
| Q2 2014 | 2014-09-30 | −$10,515 | — | — |
MedWellAI ebitda trends
Over the last five reported fiscal years, MedWellAI's ebitda decreased from −$439,428 to −$2.8M, a change of −$2.4M. The latest reported quarter, Q2 2026, shows −$259,480.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MedWellAI filings at SEC.gov ↗